Diabetes did not affect the surgical outcomes of patients with hepatitis C-related hepatocellular carcinoma following liver resection, according to results of a recently published study.
“It has been commonly understood that [diabetes] is a risk factor for the development of HCC, especially in patients with HCV infection. However, it is still controversial whether [diabetes] affects the prognosis and operative outcomes of patients with HCC,” the researchers wrote. “In the present study, [diabetes] did not appear to have a negative impact on patients’ survival after HCC resection, suggesting that [diabetes] is not an exclusion criterion for HCC surgery under good glycemic control.”
Researchers compared clinical characteristics and surgical outcomes between 112 patients with HCV-related HCC with diabetes and 112 propensity-matched patients without diabetes who underwent curative liver resection between January 2001 and December 2013.